HOME >> MEDICINE >> NEWS
Jefferson scientists create first animal model of common type of leukemia

Researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have developed the first animal model of the most common type of human leukemia. The new model should enable scientists to gain both a better understanding of the biochemical and molecular mechanisms underlying the disease, chronic lymphocytic leukemia (CLL), while at the same time provide a testing ground for potential new drugs.

"This is a very important discovery because now we have an animal model to use to develop and test new drugs," says Carlo Croce, M.D., professor and chair of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University and director of the Kimmel Cancer Center, who led the work. "The model indicates what initiates the malignancy and provides us with interesting new targets involved in the earliest steps in the disease."

Several years ago, Dr. Croce and his co-workers isolated a gene, TCL-1, located on chromosome 14, and implicated it in several types of human leukemias and lymphomas, such as T-cell CLL and adult T-cell leukemia. These cancers are characterized by chromosomal rearrangements and in turn the uncontrolled proliferation of T-cells, key infection fighting white blood cells. According to Dr. Croce, TCL-1 is also expressed in two other types of cancer: B-cell CLL and B-cell lymphoma.

"We were puzzled by the fact that all B-cell CLL expressed TCL-1," Dr. Croce explains. "Cytogenetically B-cell CLL and B-cell lymphoma do not show the translocations or rearrangements of the TCL-1 gene observed in T-cell tumors." To better understand why, Dr. Croce and his co-workers created transgenic mice in which TCL-1 essentially is put into overdrive in B-cells.

Surprisingly, they found that when the gene is hyperactive, it produces too much of its protein product, resulting in uncontrolled expansion of leukemic cells and a disease identical to human B-cell CLL. "We did not predi
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
21-May-2002


Page: 1 2

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists help explain statins effects in Alzheimers disease
5. Jefferson scientists find zinc may help prevent esophageal, oral cancers
6. Jefferson virologists coax HIV out of hiding
7. Jefferson scientists find way to see breast cancer activity from outside the body
8. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
9. Jefferson scientists use gene therapy to rescue failing hearts in animals
10. Jefferson scientists reveal how some types of rabies invade the brain
11. Jefferson neuroscientists studying new type of Alzheimers drug to halt disease progression

Post Your Comments:
(Date:3/4/2015)... 04, 2015 In a small ceremony with ... on their new facility in New Port Richey on February ... new facility will allow the Florida drug detox facility ... drug abuse epidemic through treatment and education. “Due to our ... in the United States, we made the decision that expanding ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Jeannie Mai, TV ... “The Real” graces the cover of the print publication. Mai ... to choose organic when shopping for clothes and personal care ... opens up about her commitment to an organic diet. She ... energy, not only in gymnastics, but also now as I’m ...
(Date:3/4/2015)... Hoersholm, DK (PRWEB) March 04, 2015 ... of Dako , has joined the Visiopharm ... joins Visiopharm at a time when we are positioned ... quantitative digital pathology for cancer diagnostics and research. ... invested significantly in the development and validation of ONCOtopix™ ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Problem Gambling ... time to join individuals and organizations across the nation ... general public, health care professionals, policymakers, and others about ... Council on Compulsive Gambling (FCCG) and FCCG partner organizations ... to screen patients for a gambling problem, to make ...
(Date:3/4/2015)... A new dieting routine, called the ... of extending life. Studies conducted by the ... routine can help extend life by increasing anti-oxidant production. ... term benefits, many suffering from obesity are already experiencing ... necessary. As an alternative to the new Feast and ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3
(Date:3/3/2015)... DUBLIN , March 3, 2015 Actavis ... it has priced an offering of $21 billion aggregate ... in a registered public offering to be issued by ... by certain of its other subsidiaries (the "Notes"), as ... to PublicFloating Rate Senior Notes* , $500,000,000 ...
(Date:3/3/2015)... Medical Tracking Solutions, Inc., developers of ... Brian Timberlake as Senior Vice President ... build relationships with existing and new clients. Brian brings ... and sales management as well as a deep ... comprehensive inventory management system that provides real-time tracking ...
(Date:3/3/2015)... March 3, 2015 Boston Scientific Corporation (NYSE: ... Dockendorff and Stephen P. MacMillan to its ... of the board, Uwe E. Reinhardt and ... the company,s annual meeting of stockholders in May 2015. ... executive vice president and chief financial officer of Covidien plc. ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2
Cached News: